Candela Receives FDA Clearance for Wrinkle Treatment

WAYLAND, Mass., Feb. 20 -- Candela Corp.'s Smoothbeam diode laser has received clearance from the US Food and Drug Administration for the treatment of periorbital wrinkles.

The Smoothbeam features a number of enhancements designed to optimize periorbital wrinkle treatment. Among these are a 6mm spot size, an increased range of fluence and new treatment parameters.

LATEST NEWS

• EU to Launch Lasers4MaaS Laser Welding Project
  Nov 28, 2024
• 3D Printing Consortium Seeks to Speed Industrial Adoption
  Nov 27, 2024
• Eikon Therapeutics Appoints COO: People in the News: 11/27/24
  Nov 27, 2024
• Solar Lasers Could Power Future Space Missions
  Nov 26, 2024
• Liquid Crystal Lens Filters out Light that Causes Seizures
  Nov 26, 2024
• Optimax Names Joseph Spilman CEO
  Nov 25, 2024
• Optogenetics Technique Could Replace Surgical Treatments for Seizures
  Nov 25, 2024
• Shape of a Single Photon Revealed with New Theory
  Nov 25, 2024